128 related articles for article (PubMed ID: 17024582)
1. [Discriminative ability, construct validity and sensitivity to change of the EQ-5D quality of life questionnaire in paranoid schizophrenia].
Konnopka A; Günther OH; Angermeyer MC; König HH
Psychiatr Prax; 2006 Oct; 33(7):330-6. PubMed ID: 17024582
[TBL] [Abstract][Full Text] [Related]
2. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
Günther O; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness of EQ-5D utility indices in alcohol-dependent patients.
Günther OH; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2008 Jan; 92(1-3):291-5. PubMed ID: 17888587
[TBL] [Abstract][Full Text] [Related]
4. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
5. Validation of the EQ-5D in patients with a history of acute coronary syndrome.
Ellis JJ; Eagle KA; Kline-Rogers EM; Erickson SR
Curr Med Res Opin; 2005 Aug; 21(8):1209-16. PubMed ID: 16083530
[TBL] [Abstract][Full Text] [Related]
6. [Health Status of the German population: results of a representative survey using the EuroQol questionnaire].
König HH; Bernert S; Angermeyer MC
Gesundheitswesen; 2005 Mar; 67(3):173-82. PubMed ID: 15789280
[TBL] [Abstract][Full Text] [Related]
7. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
9. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
[TBL] [Abstract][Full Text] [Related]
10. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
11. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.
König HH; Roick C; Angermeyer MC
Eur Psychiatry; 2007 Apr; 22(3):177-87. PubMed ID: 17142014
[TBL] [Abstract][Full Text] [Related]
12. [The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population].
Hinz A; Klaiberg A; Brähler E; König HH
Psychother Psychosom Med Psychol; 2006 Feb; 56(2):42-8. PubMed ID: 16453241
[TBL] [Abstract][Full Text] [Related]
13. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.
Langelaan M; de Boer MR; van Nispen RM; Wouters B; Moll AC; van Rens GH
Ophthalmic Epidemiol; 2007; 14(3):119-26. PubMed ID: 17613846
[TBL] [Abstract][Full Text] [Related]
14. [EuroQol-5D FOR quality of life assessment in cardiac rehabilitation].
Balestroni G; Omarini G; Omarini P; Zotti AM
G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B56-62. PubMed ID: 18575359
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
[TBL] [Abstract][Full Text] [Related]
16. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population.
van der Zanden BP; Dijkgraaf MG; Blanken P; de Borgie CA; van Ree JM; van den Brink W
Drug Alcohol Depend; 2006 Apr; 82(2):111-8. PubMed ID: 16168573
[TBL] [Abstract][Full Text] [Related]
17. Validation of the EQ-5D questionnaire in burn injured adults.
Oster C; Willebrand M; Dyster-Aas J; Kildal M; Ekselius L
Burns; 2009 Aug; 35(5):723-32. PubMed ID: 19297100
[TBL] [Abstract][Full Text] [Related]
18. Danish EQ-5D population norms.
Sørensen J; Davidsen M; Gudex C; Pedersen KM; Brønnum-Hansen H
Scand J Public Health; 2009 Jul; 37(5):467-74. PubMed ID: 19535407
[TBL] [Abstract][Full Text] [Related]
19. Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders.
Willems DC; Joore MA; Nieman FH; Severens JL; Wouters EF; Hendriks JJ
Int J Technol Assess Health Care; 2009 Jul; 25(3):391-9. PubMed ID: 19619359
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire.
Golicki D; Dudzińska M; Zwolak A; Tarach JS
Adv Clin Exp Med; 2015; 24(1):139-46. PubMed ID: 25923098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
